Targets and regulation of microRNA-652-3p in homoeostasis and disease

Targets and regulation of microRNA-652-3p in homoeostasis and disease.

Full text not available from this repository.
Item Type: Review
Status: Published
Official URL:
Journal or Publication Title: Journal of Molecular Medicine
Volume: 99
Number: 6
Page Range: pp. 755-769
Date: 2021
Divisions: Tuberculosis
Depositing User: General Admin
Identification Number: 10.1007/s00109-021-02060-8
ISSN: 0946-2716
Date Deposited: 10 Jun 2021 00:01

microRNA are small non-coding RNA molecules which inhibit gene expression by binding mRNA, preventing its translation. As important regulators of gene expression, there is increasing interest in microRNAs as potential diagnostic biomarkers and therapeutic targets. Studies investigating the role of one of the miRNA-miR-652-3p-detail diverse roles for this miRNA in normal cell homoeostasis and disease states, including cancers, cardiovascular disease, mental health, and central nervous system diseases. Here, we review recent literature surrounding miR-652-3p, discussing its known target genes and their relevance to disease progression. These studies demonstrate that miR-652-3p targets LLGL1 and ZEB1 to modulate cell polarity mechanisms, with impacts on cancer metastasis and asymmetric cell division. Inhibition of the NOTCH ligand JAG1 by miR-652-3p can have diverse effects on angiogenesis and immune cell regulation. Investigation of miR-652-3p and other dysregulated miRNAs identified a number of pathways potentially regulated by miR-652-3p. This review demonstrates that miR-652-3p has great promise as a diagnostic or therapeutic target due to its activity across multiple cellular systems.

Stevens, Maxwell T.
Saunders, Bernadette M.
Last Modified: 10 Jun 2021 00:01

Actions (login required)

View Item View Item